- Home
- MTA vs NVRO Comparison
MTA vs NVRO Comparison
Compare MTA & NVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTA
- NVRO
- Stock Information
- Founded
- MTA 1983
- NVRO 2006
- Country
- MTA Canada
- NVRO United States
- Employees
- MTA N/A
- NVRO N/A
- Industry
- MTA
- NVRO Medical/Dental Instruments
- Sector
- MTA
- NVRO Health Care
- Exchange
- MTA Nasdaq
- NVRO Nasdaq
- Market Cap
- MTA 267.2M
- NVRO 221.2M
- IPO Year
- MTA N/A
- NVRO 2014
- Fundamental
- Price
- MTA $2.84
- NVRO $5.85
- Analyst Decision
- MTA Hold
- NVRO Hold
- Analyst Count
- MTA 1
- NVRO 12
- Target Price
- MTA $4.50
- NVRO $7.24
- AVG Volume (30 Days)
- MTA 380.2K
- NVRO 1.3M
- Earning Date
- MTA 05-14-2025
- NVRO 03-04-2025
- Dividend Yield
- MTA N/A
- NVRO N/A
- EPS Growth
- MTA N/A
- NVRO N/A
- EPS
- MTA N/A
- NVRO N/A
- Revenue
- MTA $5,882,000.00
- NVRO $408,518,000.00
- Revenue This Year
- MTA $37.69
- NVRO $1.55
- Revenue Next Year
- MTA $120.61
- NVRO $4.36
- P/E Ratio
- MTA N/A
- NVRO N/A
- Revenue Growth
- MTA 28.55
- NVRO N/A
- 52 Week Low
- MTA $2.32
- NVRO $3.17
- 52 Week High
- MTA $4.08
- NVRO $13.84
- Technical
- Relative Strength Index (RSI)
- MTA 44.58
- NVRO 70.38
- Support Level
- MTA $2.95
- NVRO $5.83
- Resistance Level
- MTA $3.11
- NVRO $5.81
- Average True Range (ATR)
- MTA 0.13
- NVRO 0.02
- MACD
- MTA -0.01
- NVRO -0.02
- Stochastic Oscillator
- MTA 19.51
- NVRO 95.00
About MTA Metalla Royalty & Streaming Ltd.
Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.